Merck Wins Block On Teva's Generic Singulair
Merck Sharpe & Dohme Pharmaceuticals SRL has won an injunction barring Teva Pharmaceutical Industries Ltd. from making a generic version of Merck's allergy and asthma drug Singulair....To view the full article, register now.
Already a subscriber? Click here to view full article